Clinical Trial Update: Randomized Double Blind Controlled Trial Comparing the Safety and Efficacy of Apremilast Versus Placebo in Severe Forms of Recurrent Aphthous Stomatitis [Phase 3]

View source ↗

Summary

A randomized, double-blind Phase 3 trial comparing apremilast to placebo in severe recurrent aphthous stomatitis is currently recruiting. The study aims to eval…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphthous Stomatitis

Drugs mentioned

• Apremilast (Otezla) (apremilast)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Recurrent Aphtous Stomatitis | Phase 3 | Status: RECRUITING